Upper limb lean mass by Dual Energy Xray Absorptiometry is associated with increased mortality in men with advanced cirrhosisJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Mas-related G-protein coupled receptor type D (MrgD) antagonism produces splanchnic vasculature-specific effects, leading to a large reduction in portal pressure in cirrhotic animalsJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Soluble CD147 has an altered expression profile with liver disease progression and in different ethnicitiesJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1-6 infectionJOURNAL OF HEPATOLOGYIF332017-01-0140PREAI
Malnutrition is an independent predictor of immune dysfunction in cirrhotic patientsJOURNAL OF HEPATOLOGYIF332017-01-012PREAI
The alternate renin angiotensin system is upregulated and Ang-(1-7) mediates vasodilatation in human cirrhosisJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
THE EFFECT OF TESTOSTERONE THERAPYON MUSCLE MASS, BONE MASS AND HAEMOGLOBIN IN HYPOGONADAL MEN WITH CIRRHOSISJOURNAL OF HEPATOLOGYIF332016-01-012PREAI
ALL-ORAL TREATMENT WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN IN HCV GENOTYPE 3-INFECTED PATIENTS WITH ADVANCED FIBROSIS OR CIRRHOSIS: AN ANALYSIS OF ALLY-3 AND ALLY-3+JOURNAL OF HEPATOLOGYIF332016-01-011PREAI
Manipulation of dietary advanced glycation end-product content influences the progression of non-alcoholic fatty liver disease (NAFLD)JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGYIF3.42014-10-130OAAI
DIETARY GLYCOTOXINS EXACERBATE PROGRESSION OF EXPERIMENTAL FATTY LIVER DISEASEJOURNAL OF HEPATOLOGYIF332014-04-011PREAI
ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) GENE THERAPY USING A HIGH EFFICIENCY AND LIVER-SPECIFIC ADENO-ASSOCIATED VIRAL VECTOR ATTENUATES EXPERIMENTAL LIVER FIBROSIS IN MICEJOURNAL OF HEPATOLOGYIF332014-04-010PREAI
HEPATITIS C AND CYCLOSPORINE REDUCE VIABILITY AND INDUCE APOPTOSIS IN LIVER CELLSJOURNAL OF HEPATOLOGYIF332012-04-010PREAI
SOLUBLE CD163, A MARKER FOR MACROPHAGE ACTIVATION, IS NOT ASSOCIATED TO HCC, PER SE BUT PREDICTS DISEASE PROGRESSIONJOURNAL OF HEPATOLOGYIF332012-04-010PREAI
THE EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF BI201335 AND BI207127 IN GENOTYPE 1 HCV PATIENTS WITH CIRRHOSIS - INTERIM ANALYSIS FROM SOUND-C2JOURNAL OF HEPATOLOGYIF332012-04-0112PREAI
BASIGIN PREDICTS ADVANCED DISEASE IN HEPATOCELLULAR CARCINOMAJOURNAL OF HEPATOLOGYIF332012-04-010PREAI
THE EFFECT OF HOST IL28B GENOTYPE ON EARLY VIRAL KINETICS DURING INTERFERON-FREE TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C (CHC)JOURNAL OF HEPATOLOGYIF332011-03-019PREAI
TOLL-LIKE RECEPTOR 3, 7/8 AND 9 FUNCTION IS IMPAIRED IN HEPATITIS C PATIENTS WITH RAPID FIBROSIS POST LIVER TRANSPLANTJOURNAL OF HEPATOLOGYIF332011-03-010PREAI
TLR MEDIATED CYTOKINE PRODUCTION IN PRIMARY HUMAN HEPATOCYTES AND NON-PARENCHYMAL LIVER CELLSJOURNAL OF HEPATOLOGYIF332010-04-010OAAI
Spontaneous bacterial peritonitis (SBP) prophylaxis: A randomised controlled trial comparing trimethoprim-sulfamethoxazole and norfloxacinJOURNAL OF HEPATOLOGYIF332008-01-011OAAI
Chronic liver injury is associated with the upregulation of the ACE2-angiotensin-(1-7)-Mas axis in the ratJOURNAL OF HEPATOLOGYIF332007-04-010OAAI